Note M - Related Party Transactions (Details Textual) - USD ($)					3 Months Ended				12 Months Ended
	Apr. 09, 2025	Jan. 01, 2025	Apr. 06, 2021	Jul. 10, 2017	Dec. 31, 2025	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Mar. 02, 2021	Mar. 01, 2021
Royalty Expense									$ 442,059	$ 485,334
Professional Fees									$ 3,354,591	3,110,115
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]									Prime Rate [Member]
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)									0
Milestone China [Member] | Instruments [Member]
Revenues									$ 0	270,000
Director Clinical Affair [Member]
Royalty Expense									442,000	485,000
Professional Fees									156,000	156,000
Director of Clinical Affairs [Member]
Accounts Payable and Accrued Liabilities, Current									$ 110,000	114,000
Mr. Osser, Interim Chief Executive Officer [Member]
Royalty on Net Sales, Percentage											2.50%	5.00%
Mr. Osser, Vice Chairman of Board [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)			2,000,000
Shares Issued and Owned by Investors, Balance, Shares (in shares)									2,717,765
Shares To Be Issued at Employment Termination (in shares)									2,481,048
Mr. Osser, Vice Chairman of Board [Member] | Share-Based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)			5 years
Mr. Haverhals, Consultant and Director [Member] | Forecast [Member]
Payments for Consulting Services					$ 66,666	$ 66,666	$ 66,666
Mr. Haverhals, Consultant and Director [Member] | Subsequent Event [Member]
Consulting Agreement, Annual Fee		$ 350,000
Payments for Consulting Services								$ 150,000
Stock Issuable During Period, Shares, Shares to be Issued (in shares)		638,023
Mr. Neal Goldman, Ms. Benedetta Casamento, and Dr. Didier Demesmin [Member] | Forecast [Member]
Company Ownership Percentage	50.00%
Debt Instrument, Conversion Rate, Minimum Market Reference Price (in dollars per share)	$ 0.5
Mr. Neal Goldman, Ms. Benedetta Casamento, and Dr. Didier Demesmin [Member] | Forecast [Member] | Promissory Note [Member]
Debt Instrument, Face Amount	$ 800,000
Debt Instrument, Basis Spread on Variable Rate	2.50%
Debt Instrument, Equity Securities Issuance, Gross Proceeds Benchmark	$ 4,000,000
Manufacturing Agreement for Handpieces [Member]
Related Party Transaction, Purchases from Related Party									$ 1,700,000	2,300,000
Manufacturing Agreement for Handpieces [Member] | Related Party [Member] | Accounts Payable, Related Parties, Current [Member]
Accounts Payable and Accrued Liabilities									663,000	402,000
Consulting Services [Member] | Related Party [Member]
Costs and Expenses									0	100,000
Employment Agreement [Member] | Mr. Osser, Vice Chairman of Board [Member]
Increase (Decrease) in Deferred Compensation				$ (100,000)
Employment Agreement, Base Compensation				200,000
Deferred Compensation Arrangement with Individual, Compensation Expense									200,000	200,000
Consulting Agreement [Member] | Mr. Osser, Vice Chairman of Board [Member]
Increase (Decrease) in Deferred Compensation				100,000
Employment Agreement, Base Compensation				$ 200,000
Deferred Compensation Arrangement with Individual, Compensation Expense									200,000	$ 200,000
Purchased Medical Products [Member] | University Pain Medicine Center (STEMMEE) [Member]
Related Party Transaction, Amounts of Transaction									$ 21,000